Collection of Gingival Crevicular Fluid From Periodontitis Patients
NCT00763048 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2011-06-14
Summary
To collect GCF (gingival crevicular fluid) samples from diseased patients suffering only from gingivitis and/or periodontitis.
Conditions
- Gingival Diseases
Interventions
- DRUG
-
Fluoride
Brush twice daily for 6 weeks
- DRUG
-
Fluoride, triclosan
Brush twice daily
Sponsors & Collaborators
-
Colgate Palmolive
lead INDUSTRY
Principal Investigators
-
Riccardo Teles, DMD
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 26 Years
- Max Age
- 68 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
Countries
- United States
Study Locations
More Related Trials
-
Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment
NCT02390479 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assesment of Gingival Crevicular Fluid and Serum ErbB4/Neuregulin-4 Levels in Periodontal Disease and Health
NCT04051385 ·Status: COMPLETED ·Phase: NA
-
Assessment of Efficacy of Calprotectin and Cross-linked N-telopeptides
NCT04177732 ·Status: UNKNOWN ·Phase: NA
-
Fractalkine-CX3CR1 Axis in Periodontal Therapy
NCT07307144 ·Status: COMPLETED ·Phase: NA
-
Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment
NCT02660814 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
NCT05449093 ·Status: COMPLETED
-
Apoptic Biomarkers of Periodontal Disease
NCT00569075 ·Status: COMPLETED
-
Evaluating Gingivitis and Systemic Biomarkers
NCT06962956 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of Biomarker Levels in Gingival Crevicular Fluid of Patients With Different Periodontal Diseases
NCT04777487 ·Status: COMPLETED ·Phase: NA
-
Methodological Evaluation of Gingival Crevicular Fluid Volume and Elastase Level
NCT02676362 ·Status: COMPLETED ·Phase: NA
-
Evaluation of SOST, TWEAK, RANKL, OPG Levels in Smokers and Non-Smokers With Periodontitis
NCT06103578 ·Status: COMPLETED
-
Rapid Point-of-Care Salivary Diagnostic for Periodontal Health
NCT02403297 ·Status: TERMINATED
-
Neurogenic Inflammation in Peri-implant and Periodontal Diseases
NCT03663140 ·Status: COMPLETED
-
Visfatin Levels Before and After Periodontal Treatment
NCT02615626 ·Status: COMPLETED
-
Periostin and Non-Surgical Periodontal Treatment
NCT04332965 ·Status: COMPLETED ·Phase: NA
-
Gingival Crevicular Fluid Vaspin and Omentin Levels in Obese Patients With Chronic Periodontitis
NCT02563171 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis
NCT02873949 ·Status: COMPLETED ·Phase: NA
-
ESTIMATION OF GINGIVAL CREVICULAR LEVEL OF YKL40
NCT03995615 ·Status: UNKNOWN ·Phase: NA
-
IL-32 Levels in Patients With Chronic Periodontitis
NCT02632981 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Influence of PRF (Platelet-rich Fibrin) on the Clinical Parameters and the Concentration of Selected Inflammation Mediators in GCF (Gingival Crevice Fluid) of Patients With Periodontitis
NCT06920849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Galectin Role in Periodontal Disease
NCT06038812 ·Status: COMPLETED ·Phase: NA
-
Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment
NCT02750956 ·Status: COMPLETED
-
The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes
NCT03539939 ·Status: COMPLETED ·Phase: NA
-
Treatment of Advanced Grade III Periodontal Furcation Lesions
NCT05237739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Non-surgical Periodontal Therapy on Gingival Crevicular Fluid Interleukin-21 Levels
NCT02861937 ·Status: COMPLETED ·Phase: NA